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（methoxyl poly(ethylene glycol)-poly(lactic acid)，MPEG-PLA）和聚乙二醇-聚乳酸









的分析，优化选择纳米粒子载体。实验结果表明，LA/GA 比例和 PEG 含量对载药
纳米粒子粒径、Zeta 电位、载药量、包封率和收率均有显著影响。 





组装条件后，制备得的载紫杉醇 PLA 纳米粒子粒径为 557.8 nm，Zeta 电位为-45.0 
mV，收率为 37.33%，载药量为 1.44%，包封率为 12.96%，；载紫杉醇 MPEG-PLA





















子内，纳米粒子载药过程是物理包埋。体外释药实验表明，200 h 内载紫杉醇 PLA
























Paclitaxel (PTX), as a kind of hydrophobic drug, is dissolved in cremophor EL and 
ethanol as solvent for clinical use, which results in strong allergic reaction and toxicity. 
Poly lactic acid (PLA), poly(lactic-co-glycolic acid) (PLGA), methoxyl poly(ethylene 
glycol)-poly(lactic acid) (MPEG-PLA) and methoxyl poly(ethylene 
glycol)-poly(lactic-co-glycolic acid) (MPEG-PLGA) have excellent biocompatibility and 
biodegradability. Used in drug loaded nanoparticles preparation, the polymers can 
formulate controlled-release drug dosage system, and reduce toxic and side effects.  
We used dialysis method to prepared nanoparticles by self-assembling process and 
optimized self-assamble conditions. After the selection of material, we studied two 
different kinds of nanoparticles comparatively in the process of self-assamble conditions 
optimization. The main research works are as follows: 
(1) The material selection of paclitaxel loaded nanoparticles: Materials of different 
lactic acid/glycolic acid(LA/GA) ratio and poly ethylene glycol(PEG) content were used 
as drug carrier and the optimum conditions were the particle diameter, Zeta potential, 
yield coefficient, drug loadings content and encapsulation efficiency. Paclitaxel loaded 
nanoparticles were prepared by dialysis method and the optimal material was selected. 
The results showed that LA/GA ratio and PEG content significantly influenced particle 
diameter, Zeta potential, yield coefficient, drug loading content and encapsulation 
efficiency of paclitaxel loaded nanoparticles.  
(2) The optimal dialysis conditions selection of paclitaxel loaded nanoparticles: The 
materials were PLA and MPEG-PLA (10%). The variable factors were solvent, MWCO 
of dialysis bag, dialysis time, concentration, volume and PLA (MPEG-PLA)/paclitaxel 
ratio. The research objects were particle diameter, Zeta potential, yield coefficient, drug 
loadings content and encapsulation efficiency. Through the single-factor and orthogonal 
experiments, we selected the optimal dialysis conditions of paclitaxel loaded PLA 
















showed that, after the orthogonal experiments, the particle diameter of paclitaxel loaded 
PLA nanoparticle was 557.8 nm, Zeta potential was -45.0 mV, yield coefficient was 
37.33%, drug loading content was 1.44% and encapsulation efficiency was 12.96%; the 
particle diameter of paclitaxel loaded MPEG-PLA nanoparticle was 209.4 nm, Zeta 
potential was -21.5 mV, yield coefficient was 65.43%, drug loadings was 3.83% and 
encapsulation rate was 34.47%.  
(3) Physical and chemical characterization and in vitro studies of paclitaxel loaded 
nanoparticles: Physical and chemical characterization included transmission electron 
microscope observation, X-ray diffraction analysis and fourier infrared analysis. In vitro 
studies included the in vitro drug release kinetics studies, cell toxicity test and laser 
confocal microscopy observation. The results of characterizations showed that paclitaxel 
loaded PLA nanoparticles and paclitaxel loaded MPEG-PLA nanoparticles both had 
spheroidal shape, paclitaxel was amorphous in nanoparticles, embedding of paclitaxel in 
nanoparticles was physical change. The results of in vitro studies showed that, in 200 h, 
the cumulative release content of paclitaxel loaded PLA nanoparticles and paclitaxel 
loaded MPEG-PLA nanoparticles were 42.3% and 78.1%, respectively. In cell toxicity 
experiments, paclitaxel loaded nanoparticles can effectively improve the bioavailability of 
paclitaxel by the absorb effect of cells. At low concentration of paclitaxel, the survival 
rate of A549 cells co-cultured with paclitaxel loaded nanoparticles was lower than A549 
cells co-cultured with paclitaxel. 
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紫杉醇为针状晶体，熔点为 213~216 oC，难溶于水，易溶于丙酮、N, N-二甲基
甲酰胺、二甲基亚砜、四氢呋喃、二氯甲烷、甲醇、乙腈等有机溶剂。紫杉醇的分
子式为 C47H51NO14，分子质量为 853.89，其化学结构式见图 1.1。 
 
    
图 1.1 紫杉醇的化学结构式 
























































        
图 1.2 脂质体示意图 









































































































（Meso-PLA）四种。四种材料的性质应用各异：PLLA 和 PDLA 机械强度高，可用
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